Ousted L3Harris CEO Chris Kubasik forfeits $45 million—but he’ll still walk away with $80 million in stock and options

L3Harris ousted CEO Chris Kubasik (65) after a board investigation found a code-of-conduct violation, with the CEO leaving without severance and forfeiting equity worth up to about $45M (forfeited two option grants). Shares fell more than 4% on Monday, though the company reaffirmed full-year 2026 guidance across revenue, growth, and operating margin. The board installed Sam Mehta as immediate replacement and noted it avoided firing “for cause” while allowing clawbacks if misconduct is later established.

Analysis

The selloff looks like a governance-multiple shock, not a cash-flow shock. Because management explicitly ring-fenced the issue away from reporting, operations, and customer relationships, the first-order earnings impact is likely zero; the risk is a temporary discount on the stock for board/ethics uncertainty and headline overhang. In defense, that discount can persist for a few weeks even when fundamentals are unchanged, but it usually fades once investors see there is no contract fallout.

The more important second-order issue is capital allocation and strategic timing. A forced CEO transition can slow the planned monetization of the missile-propulsion asset and any related portfolio moves, which matters more for sum-of-the-parts valuation than for near-term guidance. If the new CEO is the internal segment lead, the board is signaling continuity, which reduces execution risk but may also cap the re-rating until investors get a clean 100-day plan.

Contrarian view: the board’s harsh terms actually improve the governance signal versus a softer negotiated exit, so the market may be overpricing reputational damage unless there are follow-on disclosures. The key falsifier is any additional conduct detail, a customer inquiry, or a reset to 2026 operating assumptions; absent that, the initial drawdown is more likely a tradable overreaction than the start of a fundamental de-rate.

Key Decisions for Investors

• Tactically buy LHX only on further weakness over the next 3-5 trading sessions; target a 1-2 month mean reversion as the market digests that this is not an ops/customer issue. Stop if any new disclosure, contract pause, or guidance revision appears.
• Pair trade: long LHX / short XAR for a 2-6 week governance rebound trade. The thesis is idiosyncratic underperformance can reverse without requiring defense-sector beta; cover if LHX continues to lag after the next earnings or investor update.
• Do not short LMT on this read-through. The event is too company-specific; if anything, use LMT only as a sentiment barometer for whether investors are extrapolating governance risk across primes.
• Set an alert on any update to the missile-propulsion IPO or portfolio-spinoff timeline. A delay would be a better short catalyst than the CEO change itself; if timing slips by a quarter or more, reassess the sum-of-parts premium.
• If LHX recovers to within ~2% of pre-event levels without further news, take profits quickly; the upside is limited once the governance discount normalizes.